This website uses cookies to ensure that we give you the best experience and offer services that are relevant to you. If you close this banner, scroll down or click anywhere on this page, you are giving consent to cookies being used. If you want to know more about cookies or disable some or all of them please read the Privacy Policy.

Zigabal

Specifications

Active substance	Oxcarbazepine
Package	• ZIGABAL 300 MG - 50 TABLETS IN BLISTER PVC/AL (048388019) • ZIGABAL 600 MG - 50 TABLETS IN BLISTER PVC/AL (048388021)
Class	Class A-RR
Public Price	• ZIGABAL 300 MG - 50 TABLETS IN BLISTER PVC/AL € 9,81 • ZIGABAL 600 MG - 50 TABLETS IN BLISTER PVC/AL € 18,87
VAT	10%
Therapeutic indications	As monotherapy and as adjunctive therapy in adults and children 6 years of age and older, for the treatment of partial seizures with or without secondary generalization in tonic-clonic seizures.
Posology	Read SmPC
Manufacturing Facility	-
Date of marketing	January 2023
Patent Status	Non protetto
Owner	Ecupharma S.r.l. - Via Mazzini 20 - 20123 Milan (Italy)
Read SmPC	rcp_zigabal_123.pdf

Sede legale: Via Mazzini 20, 20123 Milano
Uffici operativi: Via Newton 9/A, 20016 Pero MI

+39 02 38238790

info@ecupharma.it

Ecupharma Srl.

C. Fiscale e Partita IVA 10863670153
Tribunale di Milano Reg. Soc. N. 10863670153
CCIAA Milano N. 1412760
Capitale Sociale € 65.572,00 int. vers.

Disclaimer | Privacy Policy | Code of ethics and behavior